Clinical trials help us to understand more about migraine in children and teens, and develop innovative treatments. Listen to 12-year old Eva and her mom talk about their experience participating in a clinical trial and why they feel it's important to help advance science.
Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.